| News | Events |
| Publications | Companies |
| Clinical Trials |
Monthly Archives: April 2007
-
Contine Reading & Discuss→
-
Contine Reading & Discuss→EGM Statement
0 Replies
-
Bcl-2 Antagonist shown to be therapeutically effective in a mouse model of Chronic Lymphocytic Leukaemia Copenhagen, 18 April 2007 Santaris Pharma, the Danish biopharmaceutical company developing RNAi drugs, yesterday presented encouraging data at the American Association for Cancer Research Annual Meeting in Los Angeles, showing that SPC2996, the Company’s RNA Antagonist... Contine Reading & Discuss→Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
0 Replies

